Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Der Nervenarzt|January 20, 2007
[N-acetyl-L-cysteine as a therapeutic option in bacterial meningitis]M Klein, U Koedel, H W PfisterInfection|December 18, 2007
Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairmentM Klein, U Koedel, S Kastenbauer, et al.Stroke|December 1, 1992
Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in ratsH W Pfister, U Koedel, S Lorenzl, et al.The Journal of Infectious Diseases|May 24, 2001
Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdownF Winkler, U Koedel, S Kastenbauer, et al.Brain Research|June 19, 2001
Reactive nitrogen species contribute to blood-labyrinth barrier disruption in suppurative labyrinthitis complicating experimental pneumococcal meningitis in the ratS Kastenbauer, M Klein, U Koedel, et al.Neurology|January 24, 2002
Oxidative stress in bacterial meningitis in humansS Kastenbauer, U Koedel, B F Becker, et al.Expert Opinion on Pharmacotherapy|October 16, 2009
Therapy of community-acquired acute bacterial meningitis: the clock is runningM Klein, H W Pfister, S L Leib, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 5, 1997
L-arginine-induced regional cerebral blood flow increase is abolished after transient focal cerebral ischemia in the ratB Sporer, K H Martens, U Koedel, et al.European Journal of Pharmacology|August 7, 2002
Pneumococcal meningitis in the rat: evaluation of peroxynitrite scavengers for adjunctive therapyS Kastenbauer, U Koedel, B F Becker, et al.European Journal of Pharmacology|August 15, 2001
Experimental meningitis in the rat: protection by uric acid at human physiological blood concentrationsS Kastenbauer, U Koedel, B F Becker, et al.Pageof 6